cardiac function and renal function without an increased risk for cardiac arrhythmias. This profile differentiates istaroxime ...

Ramreddy Meka's insights shed light on a future where technology not only sustains but significantly enhances the quality of ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

On October 21, 2024, the transplant team at the Georgetown Public Hospital Corporation (GPHC), led by Dr. Kishore Persaud, ...

People who develop renal failure due to acute kidney injury or chronic kidney disease (CKD) stage 5 undergo intermittent dialysis until kidney function recovers. Patients with CKD stage 5 with ...

scPharmaceuticals Inc. ( NASDAQ: SCPH) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior ...

This is an ITK inhibitor which hopefully delivers a novel mechanism of action that inhibits multiple parallel signaling ...

Sydney FC has set its sights on cancer awareness with new partnership with Cancer Council. Elsewhere the Formula One has ...

Diabetes is a prevalent and growing health concern worldwide, affecting millions of people. With increasing rates of obesity, ...

KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, Novem ...